Panelists:

Dipti Mehta

Senior Application Scientist
Revvity

View Bio

Panelist

Dipti Mehta

Dipti Mehta has worked as a Senior Application Scientist at Revvity since 2022. Her research in DNA and protein assay development with LabChip GX Touch technology has generated new commercial assays. Her current focus on plasmid DNA and AAV characterization reflects her deep expertise in separation science, spanning techniques like gas chromatography (GC), liquid chromatography-mass spectrometry (LC-MS), ion chromatography, and microfluidics capillary electrophoresis. Her academic journey includes a Master of Technology from IIT Delhi and a prestigious DAAD scholarship to pursue research at the University of Stuttgart. She has over a decade of analytical method development across diverse industries—including biotech, oil, and chemical sectors.

Close

James White, PhD

R&D Assay Development Lead
Revvity

View Bio

Panelist

James White, PhD

James White is a R&D Assay Development Lead at Revvity, specializing in developing Microfluidic Capillary Electrophoresis assays for the LabChip™ GXII Touch™. James has led development of assays for high sensitivity nucleic acid detection and for monoclonal antibody analysis using Revvity IntelliChip™ technology. Currently, his research focuses on new methods for characterization of gene therapy products and RNA analytes. Prior to joining Revvity in 2016, James was a Postdoctoral Researcher at Tufts University in Biomedical Engineering.

Close

RNA-based therapeutics, including circular RNA, have gained significant momentum since the COVID-19 pandemic highlighted their potential in vaccine development and other forms of treatment. To date, RNA-based vaccines have garnered much of the spotlight due to their high immunogenicity, rapid development timelines, design flexibility, and higher efficacy against severe disease. However, the broader field of RNA modalities is evolving quickly. To keep pace with this progress, various technologies are being leveraged to evaluate the efficacy and safety of these therapeutic approaches.

In this GEN webinar, James White, PhD, and Dipti Mehta will explore microfluidic platforms for characterizing circular nucleic acids and other major isoforms with a high degree of reproducibility, sensitivity, and throughput.

A live Q&A session followed the presentations, offering a chance to pose questions to our expert panelists.

Produced with support from: